ALUMEM Trademark

Trademark Overview

On Friday, December 2, 2011, a trademark application was filed for ALUMEM with the United States Patent and Trademark Office. The USPTO has given the ALUMEM trademark a serial number of 85485546. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2015. This trademark is owned by Glaxo Group Limited. The ALUMEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
alumem

General Information

Serial Number85485546
Word MarkALUMEM
Filing DateFriday, December 2, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 8, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ALUMEM" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 7, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, August 10, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 10, 2015ABANDONMENT - NO USE STATEMENT FILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 9, 2014EXTENSION 5 GRANTED
Tuesday, December 2, 2014EXTENSION 5 FILED
Tuesday, December 2, 2014TEAS EXTENSION RECEIVED
Friday, June 27, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2014EXTENSION 4 GRANTED
Monday, June 23, 2014EXTENSION 4 FILED
Monday, June 23, 2014TEAS EXTENSION RECEIVED
Wednesday, January 1, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 31, 2013EXTENSION 3 GRANTED
Monday, December 16, 2013EXTENSION 3 FILED
Monday, December 16, 2013TEAS EXTENSION RECEIVED
Thursday, July 25, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 24, 2013EXTENSION 2 GRANTED
Tuesday, June 25, 2013EXTENSION 2 FILED
Wednesday, July 24, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 25, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 10, 2012EXTENSION 1 GRANTED
Monday, December 10, 2012EXTENSION 1 FILED
Monday, December 10, 2012TEAS EXTENSION RECEIVED
Tuesday, July 3, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 8, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 8, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 18, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 5, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 2, 2012ASSIGNED TO LIE
Wednesday, March 14, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 14, 2012ASSIGNED TO EXAMINER
Wednesday, December 7, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 6, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

alumem pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological